Skip to Main Content

Paper Details

Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants.
Eur Heart J
13
2021
CV death, MACE-1, MACE-2, Rosuvastatin, cardiovascular, cardiovascular disease, cholesterol, heart failure, myocardial infarction, participants, resuscitated cardiac arrest, rosuvastatin, stroke
Author NameAffiliation
Khalid YusoffUniversiti Teknologi Majlis Amansh Rakyat
Khalid YusoffUniversity College Sedaya International University
Christopher M ReidSchool of Public Health and Preventive Medicine, Monash University
Christopher M ReidThe School of Public Health, Curtin University
Salim YusufThe Population Health Research Institute
Salim YusufMcMaster University
  • 1 - 6

Datasets

Release 1.2